Vrije Universiteit Brussel, Department of Physiotherapy, Faculty of Physical Education & Physiotherapy, Laarbeeklaan 103, B-1090 Brussels, Belgium.
Trials. 2012 Feb 21;13:21. doi: 10.1186/1745-6215-13-21.
Central sensitization has recently been documented in patients with knee osteoarthritis (OAk). So far, the presence of central sensitization has not been considered as a confounding factor in studies assessing the pain inhibitory effect of tens on osteoarthritis of the knee. The purpose of this study is to explore the pain inhibitory effect of burst tens in OAk patients and to explore the prognostic value of central sensitization on the pain inhibitory effect of tens in OAk patients.
Patients with knee pain due to OAk will be recruited through advertisements in local media. Temporal summation, before and after a heterotopic noxious conditioning stimulation, will be measured. In addition, pain on a numeric rating score, WOMAC subscores for pain and function and global perceived effect will be assessed. Patients will be randomly allocated to one of two treatment groups (tens, sham tens). Follow-up measurements will be scheduled after a period of 6 and 12 weeks.
Tens influences pain through the electrical stimulation of low-threshold A-beta cutaneous fibers. The responsiveness of central pain-signaling neurons of centrally sensitized OAk patients may be augmented to the input of these electrical stimuli. This would encompass an adverse therapy effect of tens. To increase treatment effectiveness it might be interesting to identify a subgroup of symptomatic OAk patients, i.e., non-sensitized patients, who are likely to benefit from burst tens.
ClinicalTrials.gov: NCT01390285.
膝骨关节炎(OAk)患者存在中枢敏化现象已得到证实。到目前为止,在评估 TENS 对膝骨关节炎疼痛抑制作用的研究中,尚未将中枢敏化视为混杂因素。本研究旨在探讨爆发性 TENS 对 OAk 患者疼痛的抑制作用,并探讨中枢敏化对 OAk 患者 TENS 疼痛抑制作用的预测价值。
通过当地媒体广告招募膝关节疼痛的 OAk 患者。测量异源性伤害性条件刺激前后的时间总和。此外,将评估数字评分法疼痛、WOMAC 疼痛和功能子量表以及总体感知效果。患者将随机分配到两组治疗组(TENS,假 TENS)之一。在 6 周和 12 周后安排随访测量。
TENS 通过对低阈值 A-β皮肤纤维的电刺激来影响疼痛。中枢敏化 OAk 患者的中枢疼痛信号神经元对这些电刺激的反应可能会增强。这将包括 TENS 的不良治疗效果。为了提高治疗效果,识别出对爆发性 TENS 可能受益的症状性 OAk 患者亚组(即非敏化患者)可能会很有趣。
ClinicalTrials.gov:NCT01390285。